Interpace Biosciences
IDXG
#10435
Rank
S$52.86 M
Marketcap
S$8.96
Share price
0.00%
Change (1 day)
602.35%
Change (1 year)

Earnings for Interpace Biosciences (IDXG)

Earnings in 2026 (TTM): S$5.19 Million

According to Interpace Biosciences's latest financial reports the company's current earnings are S$36.14 Million. In 2025 the company made an earning of S$5.04 Million a decrease over its 2024 earnings that were of S$11.03 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Interpace Biosciences from 1997 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$5.19 M3.02%
2025 S$5.04 M-54.26%
2024 S$11.03 M303.23%
2023 S$2.73 M-144.63%
2022 -S$6.14 Million-60.98%
2021 -S$15.71 Million-52.04%
2020 -S$32.76 Million-2.68%
2019 -S$33.66 Million121.84%
2018 -S$15.18 Million-6.07%
2017 -S$16.16 Million96.31%
2016 -S$8.23 Million-86.7%
2015 -S$61.88 Million382.48%
2014 -S$12.83 Million134.35%
2013 -S$5.48 Million323.89%
2012 -S$1.3 Million-79.01%
2011 -S$6.16 Million29.08%
2010 -S$4.77 Million-82.57%
2009 -S$27.34 Million-39.28%
2008 -S$45.03 Million146.45%
2007 -S$18.28 Million-269.18%
2006 S$10.79 M-131.08%
2005 -S$34.75 Million-177.16%
2004 S$45.02 M78.33%
2003 S$25.24 M-142.02%
2002 -S$60.09 Million-469.63%
2001 S$16.25 M-68.92%
2000 S$52.3 M140.45%
1999 S$21.75 M
1997 S$3.07 M